Skip to main content
. 2021 Jul 26;69(8):2158–2163. doi: 10.4103/ijo.IJO_200_21

Figure 1.

Figure 1

(a-d): Indication, anesthetic agent, site for carrying out procedure, eye to be injected; among the respondents. (a): Indications for the use of anti-VEGF in retinopathy of prematurity (ROP). (b): Type of anesthesia preferred for the anti-VEGF injection. (c): Procedure site for the procedure. (d): Protocol for injecting anti-VEGF